{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T11:58:02.787069+00:00","company":{"ticker":"ALBT","cik":1630212,"company_name":"Avalon GloboCare Corp."},"pagination":{"limit":100,"returned":83,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC","detail":"credit_facility","count":3,"first_seen":"2023-10-13T23:59:59+00:00","last_seen":"2023-10-13T23:59:59+00:00","evidence_fact_ids":[106775,106776,106777]},{"display_name":"Wenzhao Lu","detail":"asset_purchase","count":3,"first_seen":"2022-12-14T23:59:59+00:00","last_seen":"2026-02-19T23:59:59+00:00","evidence_fact_ids":[31818,91643,191269]},{"display_name":"FirstFire Global Opportunities Fund, LLC","detail":"notes_offering","count":2,"first_seen":"2023-07-10T23:59:59+00:00","last_seen":"2026-06-04T20:30:22+00:00","evidence_fact_ids":[67502,132895]},{"display_name":"Mast Hill Fund L.P.","detail":"credit_facility","count":2,"first_seen":"2023-05-26T23:59:59+00:00","last_seen":"2024-03-27T23:59:59+00:00","evidence_fact_ids":[64726,146956]},{"display_name":"Allen O Cage Jr.","detail":"credit_facility","count":1,"first_seen":"2025-12-15T23:59:59+00:00","last_seen":"2025-12-15T23:59:59+00:00","evidence_fact_ids":[124004]},{"display_name":"Dune Equity Holdings LLC","detail":"notes_offering","count":1,"first_seen":"2026-06-04T20:30:22+00:00","last_seen":"2026-06-04T20:30:22+00:00","evidence_fact_ids":[67501]},{"display_name":"Roth Capital Partners, LLC","detail":"atm_program","count":1,"first_seen":"2023-06-16T23:59:59+00:00","last_seen":"2023-06-16T23:59:59+00:00","evidence_fact_ids":[137880]},{"display_name":"S&P Principal LLC","detail":"credit_facility","count":1,"first_seen":"2023-05-26T23:59:59+00:00","last_seen":"2023-05-26T23:59:59+00:00","evidence_fact_ids":[146955]},{"display_name":"SCBC Holdings LLC","detail":"asset_purchase","count":1,"first_seen":"2022-11-08T23:59:59+00:00","last_seen":"2022-11-08T23:59:59+00:00","evidence_fact_ids":[198538]},{"display_name":"Vanquish Funding Group, Inc.","detail":"equity_purchase","count":1,"first_seen":"2026-02-18T23:59:59+00:00","last_seen":"2026-02-18T23:59:59+00:00","evidence_fact_ids":[32008]},{"display_name":"YOOV Group Holding Limited","detail":"merger","count":1,"first_seen":"2026-01-22T23:59:59+00:00","last_seen":"2026-01-22T23:59:59+00:00","evidence_fact_ids":[34894]}],"lender":[{"display_name":"Firstfire Global Opportunities Fund, LLC","detail":"loan","count":3,"first_seen":"2023-07-10T23:59:59+00:00","last_seen":"2026-06-04T20:30:22+00:00","evidence_fact_ids":[67505,106783,132896]},{"display_name":"Mast Hill Fund, L.P.","detail":"convertible_notes","count":3,"first_seen":"2023-05-26T23:59:59+00:00","last_seen":"2024-03-27T23:59:59+00:00","evidence_fact_ids":[64728,106782,146959]},{"display_name":"Allen O Cage Jr.","detail":"loan","count":1,"first_seen":"2025-12-15T23:59:59+00:00","last_seen":"2025-12-15T23:59:59+00:00","evidence_fact_ids":[36729]},{"display_name":"Dune Equity Holdings LLC","detail":"loan","count":1,"first_seen":"2026-06-04T20:30:22+00:00","last_seen":"2026-06-04T20:30:22+00:00","evidence_fact_ids":[67504]},{"display_name":"S&P Principal LLC","detail":"mortgage","count":1,"first_seen":"2023-05-26T23:59:59+00:00","last_seen":"2023-05-26T23:59:59+00:00","evidence_fact_ids":[146958]},{"display_name":"Vanquish Funding Group, Inc.","detail":"other","count":1,"first_seen":"2026-02-18T23:59:59+00:00","last_seen":"2026-02-18T23:59:59+00:00","evidence_fact_ids":[33526]}],"ma_counterparty":[{"display_name":"RPM INTERACTIVE, INC.","detail":"acquisition","count":1,"first_seen":"2025-12-15T23:59:59+00:00","last_seen":"2025-12-15T23:59:59+00:00","evidence_fact_ids":[25922]},{"display_name":"SCBC Holdings LLC","detail":"acquisition","count":1,"first_seen":"2023-02-13T23:59:59+00:00","last_seen":"2023-02-13T23:59:59+00:00","evidence_fact_ids":[179857]},{"display_name":"Wenzhao Lu","detail":"disposition","count":1,"first_seen":"2026-02-19T23:59:59+00:00","last_seen":"2026-02-19T23:59:59+00:00","evidence_fact_ids":[24731]}]},"facts":[{"fact_type":"shareholder_vote","fact_key":"73525710654e83556a67251207539d9908d56857","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Approval to give the Board authority to effect a reverse stock split of the Company's issued common stock at a ratio between 1-for-2 and 1-for-25, with the exact ratio to be selected by the Board, to be effected before June 9, 2027 (the 'Reverse Stock Split Proposal')","proposal_type":"reverse_split","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"17,952","votes_against":"741,154","votes_for":"3,605,584","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approval to give the Board authority to effect a reverse stock split of the Company's issued common stock at a ratio between 1-for-2 and 1-for-25, with the exact ratio to be selected by the Board, to be effected before June 9, 2027 (the 'Reverse Stock Split Proposal') at the 2026-06-09 meeting.","evidence_excerpt":"the stockholders approved the Reverse Stock Split Proposal. The result of the votes to approve the Reverse Stock Split Proposal was as follows: For Against Abstain Broker Non-Votes 3,605,584 741,154 17,952 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-73525710654e83556a67251207539d9908d56857","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"shareholder_vote","fact_key":"c62be47d8d826ffb008fdd83f78bdf46d6cf7d8b","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Approval, for the purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of Series A-1 Warrants, Series A-2 Warrants, Placement Agent Warrants and shares issuable upon exercise thereof in connection with the February 2026 private placement (the 'February 2026 Warrant Issuance Propos","proposal_type":"other","results":[{"broker_non_votes":"2,863,700","subject":null,"votes_abstain":"4,417","votes_against":"570,691","votes_for":"925,882","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approval, for the purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of Series A-1 Warrants, Series A-2 Warrants, Placement Agent Warrants and shares issuable upon exercise thereof in connection with the February 2026 private placement (the 'February 2026 Warrant Issuance Propos at the 2026-06-09 meeting.","evidence_excerpt":"the stockholders approved the February 2026 Warrant Issuance Proposal. The result of the votes to approve the February 2026 Warrant Issuance Proposal was as follows: For Against Abstain Broker Non-Votes 925,882 570,691 4,417 2,863,700","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-c62be47d8d826ffb008fdd83f78bdf46d6cf7d8b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3239160df284feeef4b96899be262a50587cf006","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Advisory approval of the 2025 compensation of our named executive officer (the 'Say-on-Pay Proposal')","proposal_type":"say_on_pay","results":[{"broker_non_votes":"2,863,700","subject":null,"votes_abstain":"54,328","votes_against":"32,635","votes_for":"1,414,027","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Advisory approval of the 2025 compensation of our named executive officer (the 'Say-on-Pay Proposal') at the 2026-06-09 meeting.","evidence_excerpt":"the stockholders approved the Say-on-Pay Proposal . The result of the votes to approve the Say-on-Pay Proposal was as follows: For Against Abstain Broker Non-Votes 1,414,027 32,635 54,328 2,863,700","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-3239160df284feeef4b96899be262a50587cf006","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d5c4afafa4232c8636d4c23dd35af1e2cd81e1bd","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Approval of the Avalon GloboCare Corp. 2026 Stock Incentive Plan (the '2026 Plan Proposal')","proposal_type":"equity_plan","results":[{"broker_non_votes":"2,863,700","subject":null,"votes_abstain":"1,578","votes_against":"618,585","votes_for":"880,827","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approval of the Avalon GloboCare Corp. 2026 Stock Incentive Plan (the '2026 Plan Proposal') at the 2026-06-09 meeting.","evidence_excerpt":"the stockholders approved the 2026 Plan Proposal. The result of the votes to approve the 2026 Plan Proposal was as follows: For Against Abstain Broker Non-Votes 880,827 618,585 1,578 2,863,700","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-d5c4afafa4232c8636d4c23dd35af1e2cd81e1bd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"shareholder_vote","fact_key":"68b9894ffc253c03bf554afc3e473511fd086b60","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Ratification of the appointment of M&K CPAS, PLLC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"3,357","votes_against":"110,736","votes_for":"4,250,597","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Ratification of the appointment of M&K CPAS, PLLC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.","evidence_excerpt":"appointment of M&K as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non-Votes 4,250,597 110,736 3,357 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-68b9894ffc253c03bf554afc3e473511fd086b60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e0775c7234420a7a115d1f7e29eb68391b9690c0","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-09T21:15:29+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-09","outcome":"passed","proposal_text":"Election of four (4) members of the Board to serve for a one-year term to expire at the 2027 annual meeting","proposal_type":"director_election","results":[{"broker_non_votes":"2,863,700","subject":"Wenzhao \"Daniel\" Lu","votes_abstain":null,"votes_against":null,"votes_for":"1,141,805","votes_withheld":"359,185"},{"broker_non_votes":"2,863,700","subject":"Lourdes Felix","votes_abstain":null,"votes_against":null,"votes_for":"1,411,624","votes_withheld":"89,366"},{"broker_non_votes":"2,863,700","subject":"Steven A. Sanders","votes_abstain":null,"votes_against":null,"votes_for":"1,435,430","votes_withheld":"65,560"},{"broker_non_votes":"2,863,700","subject":"Michael Mathews","votes_abstain":null,"votes_against":null,"votes_for":"1,440,611","votes_withheld":"60,379"}]},"claim":"Avalon GloboCare Corp. shareholders approved Election of four (4) members of the Board to serve for a one-year term to expire at the 2027 annual meeting at the 2026-06-09 meeting.","evidence_excerpt":"All of the four (4) nominees for director were elected to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-066880","anchor_url":"https://secwatch.observer/filing/0001213900-26-066880#claim-e0775c7234420a7a115d1f7e29eb68391b9690c0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026066880/0001213900-26-066880-index.htm"},{"fact_type":"executive_change","fact_key":"d1a7f2f26f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-03","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Sam Knipper was appointed as Chief Financial Officer at Avalon GloboCare Corp..","evidence_excerpt":"On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-d1a7f2f26f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"executive_change","fact_key":"5ec6356936","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-03","interim":false,"role":"Chief Strategy Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Luisa Ingargiola was appointed as Chief Strategy Officer at Avalon GloboCare Corp..","evidence_excerpt":"On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-5ec6356936","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"debt_financing","fact_key":"40c70b22b774c4b5c7a77e8206f66f222f4cb9f2","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"counterparty":"FirstFire Global Opportunities Fund, LLC","effective_date":"2026-06-02","event":"incurrence","instrument_type":"loan","interest_rate_text":"18.75% of the principal amount","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$250,000"},"claim":"Avalon GloboCare Corp. incurred loan of $250,000 with FirstFire Global Opportunities Fund, LLC at 18.75% of the principal amount.","evidence_excerpt":"On June 2, 2026 (the “FirstFire Issue Date”), the Company issued promissory note to FirstFire Global Opportunities Fund, LLC (“FirstFire”) in the principal amount of $250,000 (inclusive of a $50,000 original issuance discount) (the “FirstFire Note”) for gross proceeds of $200,000 on the same terms and conditions of the Dune Note described above.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-40c70b22b774c4b5c7a77e8206f66f222f4cb9f2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"debt_financing","fact_key":"b2c3857e137f058c94114614a880774782c6bf6b","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"counterparty":"Dune Equity Holdings LLC","effective_date":"2026-06-01","event":"incurrence","instrument_type":"loan","interest_rate_text":"18.75% of the principal amount","item_codes_triggered":["2.03"],"maturity_text":"December 1, 2026","principal_text":"$250,000"},"claim":"Avalon GloboCare Corp. incurred loan of $250,000 with Dune Equity Holdings LLC at 18.75% of the principal amount maturing December 1, 2026.","evidence_excerpt":"On June 1, 2026 (the “Dune Issue Date”), Avalon Globocare Corp. (the “Company”) issued promissory note to Dune Equity Holdings LLC (“Dune”) in the principal amount of $250,000 (inclusive of a $50,000 original issuance discount) (the “Dune Note”) for gross proceeds of $200,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-b2c3857e137f058c94114614a880774782c6bf6b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"material_agreement","fact_key":"abb17475efa94b6632a47e48c27ea7de43696a4f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"action":"entry","agreement_name":"Promissory Note to FirstFire Global Opportunities Fund, LLC","agreement_type":"notes_offering","counterparty":"FirstFire Global Opportunities Fund, LLC","effective_date":"2026-06-02","item_codes_triggered":["1.01","1.02"],"value_text":"$250,000 principal amount, $200,000 gross proceeds"},"claim":"Avalon GloboCare Corp. entered into Promissory Note to FirstFire Global Opportunities Fund, LLC with FirstFire Global Opportunities Fund, LLC valued at $250,000 principal amount, $200,000 gross proceeds (effective 2026-06-02).","evidence_excerpt":"On June 2, 2026 (the “FirstFire Issue Date”), the Company issued promissory note to FirstFire Global Opportunities Fund, LLC (“FirstFire”) in the principal amount of $250,000 (inclusive of a $50,000 original issuance discount) (the “FirstFire Note”) for gross proceeds of $200,000 on the same terms and conditions of the Dune Note described above.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-abb17475efa94b6632a47e48c27ea7de43696a4f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"material_agreement","fact_key":"85d9b5f74b56a8f34cbc84256690059c88d25032","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-06-04T20:30:22+00:00","payload":{"action":"entry","agreement_name":"Promissory Note to Dune Equity Holdings LLC","agreement_type":"notes_offering","counterparty":"Dune Equity Holdings LLC","effective_date":"2026-06-01","item_codes_triggered":["1.01","1.02"],"value_text":"$250,000 principal amount, $200,000 gross proceeds"},"claim":"Avalon GloboCare Corp. entered into Promissory Note to Dune Equity Holdings LLC with Dune Equity Holdings LLC valued at $250,000 principal amount, $200,000 gross proceeds (effective 2026-06-01).","evidence_excerpt":"On June 1, 2026 (the “Dune Issue Date”), Avalon Globocare Corp. (the “Company”) issued promissory note to Dune Equity Holdings LLC (“Dune”) in the principal amount of $250,000 (inclusive of a $50,000 original issuance discount) (the “Dune Note”) for gross proceeds of $200,000.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-065318","anchor_url":"https://secwatch.observer/filing/0001213900-26-065318#claim-85d9b5f74b56a8f34cbc84256690059c88d25032","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026065318/0001213900-26-065318-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"44db8dfd7dd06fde1167ab3361b33b8f287c35e6","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-04-17T23:59:59+00:00","payload":{"company_response":"monitoring","compliance_status":"deficient","cure_deadline":"2026-10-12","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$1.00 per share","notice_date":"2026-04-15","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"April 15, 2026, Avalon GloboCare Corp. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq\nStock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing\nRule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain\na minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement\nexists if the deficiency continues for a period of 30 consecutive business days. B","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-045160","anchor_url":"https://secwatch.observer/filing/0001213900-26-045160#claim-44db8dfd7dd06fde1167ab3361b33b8f287c35e6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026045160/0001213900-26-045160-index.htm"},{"fact_type":"equity_issuance","fact_key":"375dd4263fa8d54d59ec6d32d39acbe3df6699c3","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"conversion","consideration_text":"net-exercise basis, no proceeds received","effective_date":"2026-02-26","item_codes_triggered":["3.02"],"purchaser":"warrant holders","security_type":"common_stock","shares_text":"287,411 shares (Feb 19), 230,739 shares (Feb 24), 750,522 shares (Feb 26)"},"claim":"Avalon GloboCare Corp. issued 287,411 shares (Feb 19), 230,739 shares (Feb 24), 750,522 shares (Feb 26) of common stock to warrant holders for net-exercise basis, no proceeds received.","evidence_excerpt":"On each of February 19, 2026, February 24, 2026 and February 26, 2026, the Company issued 287,411, 230,739 and 750,522 shares of its common stock, respectively upon exercise of existing warrants on a net-exercise basis. The February 24, 2026 issuance of warrant exercise shares triggered the disclosure requirement under this Item 3.02. No proceeds were received upon exercise.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-375dd4263fa8d54d59ec6d32d39acbe3df6699c3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"075d2f2572048b81cdcf299aee8d7a494d694ca3","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"cash fee of 7.0% of aggregate gross proceeds plus management fee","effective_date":"2026-02-26","item_codes_triggered":["3.02","3.03"],"purchaser":"H.C. Wainwright & Co., LLC (Placement Agent)","security_type":"warrant","shares_text":"Placement Agent Warrants to purchase up to 318,628 shares of Common Stock"},"claim":"Avalon GloboCare Corp. issued Placement Agent Warrants to purchase up to 318,628 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC (Placement Agent) for cash fee of 7.0% of aggregate gross proceeds plus management fee.","evidence_excerpt":"H.C. Wainwright & Co., LLC as the exclusive placement agent in connection with the Private Placement (the “ Placement\nAgent ”), the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds raised in the Private Placement,\nplus a management fee equal to 1.0% of the gross proceeds raised in the Private Placement and reimbursement of","confidence":0.97,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-075d2f2572048b81cdcf299aee8d7a494d694ca3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"da6a4ee7189963bba0dd5fbd8a376af2f2e12e9d","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"Each Warrant has an exercise price of $0.51 per share","effective_date":"2026-02-26","item_codes_triggered":["3.02","3.03"],"purchaser":"institutional investors","security_type":"warrant","shares_text":"Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock"},"claim":"Avalon GloboCare Corp. issued Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock of warrant to institutional investors for Each Warrant has an exercise price of $0.51 per share.","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the \" Company \") entered into securities purchase agreements (the \" Purchase Agreements \") with certain institutional investors (\"the \" Purchasers \") for the issuance and sale in a private placement (the \" Private Placement \") of (i) 490,197 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per shares (\" Common Stock \") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the \"Pre-Funded Warrants\") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the \" Pre-Funded Warrant Shares \"); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-1 Warrants ,\" and the shares issuable upon exercise thereof, the \" Series A-1 Warrant Shares \") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-2 Warrants ,\" together with the Series A-1 Warrants, the \" Warrants \") and t","confidence":0.97,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-da6a4ee7189963bba0dd5fbd8a376af2f2e12e9d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"2b524f3a0f0983dc1114a7b227e6b0dfa5fd61ae","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"Each Warrant has an exercise price of $0.51 per share","effective_date":"2026-02-26","item_codes_triggered":["3.02","3.03"],"purchaser":"institutional investors","security_type":"warrant","shares_text":"Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock"},"claim":"Avalon GloboCare Corp. issued Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock of warrant to institutional investors for Each Warrant has an exercise price of $0.51 per share.","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the \" Company \") entered into securities purchase agreements (the \" Purchase Agreements \") with certain institutional investors (\"the \" Purchasers \") for the issuance and sale in a private placement (the \" Private Placement \") of (i) 490,197 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per shares (\" Common Stock \") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the \"Pre-Funded Warrants\") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the \" Pre-Funded Warrant Shares \"); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-1 Warrants ,\" and the shares issuable upon exercise thereof, the \" Series A-1 Warrant Shares \") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-2 Warrants ,\" together with the Series A-1 Warrants, the \" Warrants \") and t","confidence":0.97,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-2b524f3a0f0983dc1114a7b227e6b0dfa5fd61ae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"a0099c523844562d53d4d6235260d091fdbbcc73","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"$0.5099 per Pre-Funded Warrant","effective_date":"2026-02-26","item_codes_triggered":["3.02","3.03"],"purchaser":"institutional investors","security_type":"warrant","shares_text":"pre-funded warrants to purchase up to 5,882,353 shares of Common Stock"},"claim":"Avalon GloboCare Corp. issued pre-funded warrants to purchase up to 5,882,353 shares of Common Stock of warrant to institutional investors for $0.5099 per Pre-Funded Warrant.","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the \" Company \") entered into securities purchase agreements (the \" Purchase Agreements \") with certain institutional investors (\"the \" Purchasers \") for the issuance and sale in a private placement (the \" Private Placement \") of (i) 490,197 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per shares (\" Common Stock \") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the \"Pre-Funded Warrants\") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the \" Pre-Funded Warrant Shares \"); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-1 Warrants ,\" and the shares issuable upon exercise thereof, the \" Series A-1 Warrant Shares \") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-2 Warrants ,\" together with the Series A-1 Warrants, the \" Warrants \") and t","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-a0099c523844562d53d4d6235260d091fdbbcc73","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"eafc38a19a957773c11e82ad166c2f43bad569e7","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"$0.51 per Share","effective_date":"2026-02-26","item_codes_triggered":["3.02","3.03"],"purchaser":"institutional investors","security_type":"common_stock","shares_text":"490,197 shares"},"claim":"Avalon GloboCare Corp. issued 490,197 shares of common stock to institutional investors for $0.51 per Share.","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the \" Company \") entered into securities purchase agreements (the \" Purchase Agreements \") with certain institutional investors (\"the \" Purchasers \") for the issuance and sale in a private placement (the \" Private Placement \") of (i) 490,197 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per shares (\" Common Stock \") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the \"Pre-Funded Warrants\") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the \" Pre-Funded Warrant Shares \"); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-1 Warrants ,\" and the shares issuable upon exercise thereof, the \" Series A-1 Warrant Shares \") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the \" Series A-2 Warrants ,\" together with the Series A-1 Warrants, the \" Warrants \") and t","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-eafc38a19a957773c11e82ad166c2f43bad569e7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"material_agreement","fact_key":"220f95888b924bf565e00a4dece75a64e273c0a0","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Registration Rights Agreement","agreement_type":"other","counterparty":"certain institutional investors","effective_date":"2026-02-26","item_codes_triggered":["1.01"],"value_text":null},"claim":"Avalon GloboCare Corp. entered into Registration Rights Agreement with certain institutional investors (effective 2026-02-26).","evidence_excerpt":"the Company entered into a registration rights agreement (the \" Registration Rights Agreement \"), dated as of February 26, 2026, with the Purchaser","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-220f95888b924bf565e00a4dece75a64e273c0a0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"material_agreement","fact_key":"bb3c49645effcbe51e91c5f8ca49dade283fdb96","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreements","agreement_type":"equity_purchase","counterparty":"certain institutional investors","effective_date":"2026-02-26","item_codes_triggered":["1.01"],"value_text":null},"claim":"Avalon GloboCare Corp. entered into Purchase Agreements with certain institutional investors (effective 2026-02-26).","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the \" Company \") entered into securities purchase agreements (the \" Purchase Agreements \") with certain institutional investors (\"the \" Purchasers \") for the issuance and sale in a private placement","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-033624","anchor_url":"https://secwatch.observer/filing/0001213900-26-033624#claim-bb3c49645effcbe51e91c5f8ca49dade283fdb96","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026033624/0001213900-26-033624-index.htm"},{"fact_type":"equity_issuance","fact_key":"745b81b4dd714910d19026d76fae21eb6e9fc3a6","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"conversion","consideration_text":"Net-exercise basis, no proceeds received","effective_date":"2026-02-26","item_codes_triggered":["3.02"],"purchaser":"Existing warrant holders","security_type":"common_stock","shares_text":"231,850 shares of common stock"},"claim":"Avalon GloboCare Corp. issued 231,850 shares of common stock of common stock to Existing warrant holders for Net-exercise basis, no proceeds received.","evidence_excerpt":"On each of February 19, 2026, February 24, 2026 and February 26, 2026, the Company issued 287,411, 230,739 and 231,850 shares of its common stock, respectively upon exercise of existing warrants on a net-exercise basis.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-745b81b4dd714910d19026d76fae21eb6e9fc3a6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"equity_issuance","fact_key":"4955829c57114b8c4d91527b2644797c51d4fd38","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"conversion","consideration_text":"Net-exercise basis, no proceeds received","effective_date":"2026-02-24","item_codes_triggered":["3.02"],"purchaser":"Existing warrant holders","security_type":"common_stock","shares_text":"230,739 shares of common stock"},"claim":"Avalon GloboCare Corp. issued 230,739 shares of common stock of common stock to Existing warrant holders for Net-exercise basis, no proceeds received.","evidence_excerpt":"On each of February 19, 2026, February 24, 2026 and February 26, 2026, the Company issued 287,411, 230,739 and 231,850 shares of its common stock, respectively upon exercise of existing warrants on a net-exercise basis.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-4955829c57114b8c4d91527b2644797c51d4fd38","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"equity_issuance","fact_key":"6c0dc24880b16fbac1986bd11b5aebbbdc1ae027","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"conversion","consideration_text":"Net-exercise basis, no proceeds received","effective_date":"2026-02-19","item_codes_triggered":["3.02"],"purchaser":"Existing warrant holders","security_type":"common_stock","shares_text":"287,411 shares of common stock"},"claim":"Avalon GloboCare Corp. issued 287,411 shares of common stock of common stock to Existing warrant holders for Net-exercise basis, no proceeds received.","evidence_excerpt":"On each of February 19, 2026, February 24, 2026 and February 26, 2026, the Company issued 287,411, 230,739 and 231,850 shares of its common stock, respectively upon exercise of existing warrants on a net-exercise basis.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-6c0dc24880b16fbac1986bd11b5aebbbdc1ae027","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"equity_issuance","fact_key":"e38ec3a22877f28e16e66dcc209908188606abec","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"Each warrant has an exercise price of $0.51 per share; issued as part of private placement","effective_date":"2026-02-27","item_codes_triggered":["3.02"],"purchaser":"Certain institutional investors","security_type":"warrant","shares_text":"6,372,550 Series A-2 warrants to purchase common stock"},"claim":"Avalon GloboCare Corp. issued 6,372,550 Series A-2 warrants to purchase common stock of warrant to Certain institutional investors for Each warrant has an exercise price of $0.51 per share; issued as part of private placement.","evidence_excerpt":"placement (the\n“ Private Placement ”) of (i) 490,197 shares (the “Shares”) of the Company’s common stock, par value\n$0.0001 per shares (“ Common Stock ”) at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the “Pre-Funded\nWarrants”) at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-e38ec3a22877f28e16e66dcc209908188606abec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"equity_issuance","fact_key":"8a4af761c37cffd5e200ee44240b6c314679efdf","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"warrant_issuance","consideration_text":"Each warrant has an exercise price of $0.51 per share; issued as part of private placement","effective_date":"2026-02-27","item_codes_triggered":["3.02"],"purchaser":"Certain institutional investors","security_type":"warrant","shares_text":"6,372,550 Series A-1 warrants to purchase common stock"},"claim":"Avalon GloboCare Corp. issued 6,372,550 Series A-1 warrants to purchase common stock of warrant to Certain institutional investors for Each warrant has an exercise price of $0.51 per share; issued as part of private placement.","evidence_excerpt":"placement (the\n“ Private Placement ”) of (i) 490,197 shares (the “Shares”) of the Company’s common stock, par value\n$0.0001 per shares (“ Common Stock ”) at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the “Pre-Funded\nWarrants”) at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-8a4af761c37cffd5e200ee44240b6c314679efdf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"material_agreement","fact_key":"224f2aef8be1ed99202deb66ca2dd29c8198919e","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreements","agreement_type":"equity_purchase","counterparty":"certain institutional investors","effective_date":"2026-02-26","item_codes_triggered":["1.01"],"value_text":null},"claim":"Avalon GloboCare Corp. entered into Purchase Agreements with certain institutional investors (effective 2026-02-26).","evidence_excerpt":"On February 26, 2026, Avalon GloboCare Corp. (the “ Company ”) entered into securities purchase agreements (the “ Purchase Agreements ”) with certain institutional investors","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-022022","anchor_url":"https://secwatch.observer/filing/0001213900-26-022022#claim-224f2aef8be1ed99202deb66ca2dd29c8198919e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm"},{"fact_type":"equity_issuance","fact_key":"71e4170b697c14d2c1b926d68c641a45abdbd95c","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-25T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"gross proceeds of $207,000","effective_date":"2026-02-19","item_codes_triggered":["3.02"],"purchaser":"an accredited investor","security_type":"convertible_note","shares_text":null},"claim":"Avalon GloboCare Corp. issued convertible note to an accredited investor for gross proceeds of $207,000.","evidence_excerpt":"On February 19, 2026 (the “Issuance Date”), Avalon Globocare Corp. (the “Company”) entered into a securities purchase agreement (the “SPA”) with an accredited investor pursuant to which the Company issued to the investor a promissory note in the principal amount of $233,910 (inclusive of a $26,910 original issuance discount) (the “Note”) for gross proceeds of $207,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-020426","anchor_url":"https://secwatch.observer/filing/0001213900-26-020426#claim-71e4170b697c14d2c1b926d68c641a45abdbd95c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026020426/0001213900-26-020426-index.htm"},{"fact_type":"material_agreement","fact_key":"b64dbbbaa2e6b598550da7db322bf9d1f75edeb2","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"SPA","agreement_type":"equity_purchase","counterparty":"an accredited investor","effective_date":"2026-02-19","item_codes_triggered":["1.01"],"value_text":"$233,910 (inclusive of a $26,910 original issuance discount)"},"claim":"Avalon GloboCare Corp. entered into SPA with an accredited investor valued at $233,910 (inclusive of a $26,910 original issuance discount) (effective 2026-02-19).","evidence_excerpt":"On February 19, 2026 (the “Issuance Date”), Avalon Globocare Corp. (the “Company”) entered into a securities purchase agreement (the “SPA”) with an accredited investor pursuant to which the Company issued to the investor a promissory note in the principal amount of $233,910 (inclusive of a $26,910 original issuance discount) (the “Note”) for gross proceeds of $207,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-020426","anchor_url":"https://secwatch.observer/filing/0001213900-26-020426#claim-b64dbbbaa2e6b598550da7db322bf9d1f75edeb2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026020426/0001213900-26-020426-index.htm"},{"fact_type":"material_agreement","fact_key":"0ffd7e9b4a1d85cc464a4558e52ad05cad23640f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-19T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment #2","agreement_type":"other","counterparty":null,"effective_date":"2026-02-15","item_codes_triggered":["1.01"],"value_text":null},"claim":"Avalon GloboCare Corp. amended Amendment #2 (effective 2026-02-15).","evidence_excerpt":"On February 15, 2026, the Company entered into Amendment #2 (the “Note Amendment”) to unsecured bridge note dated December 11, 2025 in the original principal amount of $375,000 (the “Note”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-018475","anchor_url":"https://secwatch.observer/filing/0001213900-26-018475#claim-0ffd7e9b4a1d85cc464a4558e52ad05cad23640f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026018475/0001213900-26-018475-index.htm"},{"fact_type":"material_agreement","fact_key":"9dba76003258f0ca59da7d5f4b56954664ddd5df","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-19T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended and Restated Membership Interest Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Wenzhao Lu","effective_date":"2026-02-18","item_codes_triggered":["1.01"],"value_text":"amended aggregated purchase price of $9,000,000"},"claim":"Avalon GloboCare Corp. amended Amended and Restated Membership Interest Purchase Agreement with Wenzhao Lu valued at amended aggregated purchase price of $9,000,000 (effective 2026-02-18).","evidence_excerpt":"On February 18, 2026, the Company and the Purchaser entered into an Amended and Restated Membership Interest Purchase Agreement (the “Amended MIPA”), pursuant to which the Company sold to the Purchaser 100% of the membership interests of Avalon RT9 for (i) the Cash Consideration and (ii) the satisfaction, in full, of an approximately $5,900,000 balance due on an existing mortgage financing.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-018475","anchor_url":"https://secwatch.observer/filing/0001213900-26-018475#claim-9dba76003258f0ca59da7d5f4b56954664ddd5df","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026018475/0001213900-26-018475-index.htm"},{"fact_type":"ma_transaction","fact_key":"b218e26e0e1bf3f58457e6439b876a75877a084b","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-19T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2026-02-18","consideration_text":"$9,000,000","counterparty":"Wenzhao Lu","effective_date":"2026-02-18","item_codes_triggered":["2.01"]},"claim":"Avalon GloboCare Corp. completed a disposition involving Wenzhao Lu for $9,000,000 (closed 2026-02-18).","evidence_excerpt":"and (ii) the satisfaction, in full,\nof an approximately $5,900,000 balance due on an existing mortgage financing. This represents a total amended aggregated purchase price\nof $9,000,000. As a result of the closing of this transaction, the Company has been relieved of all obligations as a guarantor on the\nmortgage that was associated with the property owned by","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-018475","anchor_url":"https://secwatch.observer/filing/0001213900-26-018475#claim-b218e26e0e1bf3f58457e6439b876a75877a084b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026018475/0001213900-26-018475-index.htm"},{"fact_type":"debt_financing","fact_key":"b252afbcae5fdf8fa2901f4e9579bbbba7833a8e","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-18T23:59:59+00:00","payload":{"counterparty":"Vanquish Funding Group, Inc.","effective_date":"2026-02-11","event":"incurrence","instrument_type":"other","interest_rate_text":"12%","item_codes_triggered":["2.03"],"maturity_text":"February 15, 2027","principal_text":"$233,910"},"claim":"Avalon GloboCare Corp. incurred debt of $233,910 with Vanquish Funding Group, Inc. at 12% maturing February 15, 2027.","evidence_excerpt":"Funding Group, Inc. (the “Lender”), a Virginia corporation, under which it issued a promissory\nnote dated February 11, 2026 on February 12, 2026 in the principal amount of $233,910, for a purchase price of $207,000, reflecting an\noriginal issue discount of $26,910 (the “Note”). The Note carries a one-time interest charge of 12% and is repayable in","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-018003","anchor_url":"https://secwatch.observer/filing/0001213900-26-018003#claim-b252afbcae5fdf8fa2901f4e9579bbbba7833a8e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026018003/0001213900-26-018003-index.htm"},{"fact_type":"material_agreement","fact_key":"880f71adc39b7ac2e484b87f009353ae99c8b0cd","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-02-18T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Vanquish Funding Group, Inc.","effective_date":"2026-02-12","item_codes_triggered":["1.01"],"value_text":"$233,910"},"claim":"Avalon GloboCare Corp. entered into Purchase Agreement with Vanquish Funding Group, Inc. valued at $233,910 (effective 2026-02-12).","evidence_excerpt":"On February 12, 2026, Avalon GoboCare Corp. (the “Company”) entered into a Securities Purchase Agreements dated February 11, 2026 (the “Purchase Agreement”) with Vanquish Funding Group, Inc. (the “Lender”), a Virginia corporation, under which it issued a promissory note dated February 11, 2026 on February 12, 2026 in the principal amount of $233,910, for a purchase price of $207,000, reflecting an original issue discount of $26,910 (the “Note”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-018003","anchor_url":"https://secwatch.observer/filing/0001213900-26-018003#claim-880f71adc39b7ac2e484b87f009353ae99c8b0cd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026018003/0001213900-26-018003-index.htm"},{"fact_type":"material_agreement","fact_key":"ab499f6e0165ce61f6822a05d1b8d0be658805b8","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2026-01-22T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Merger Agreement","agreement_type":"merger","counterparty":"YOOV Group Holding Limited","effective_date":"2026-01-21","item_codes_triggered":["1.02"],"value_text":null},"claim":"Avalon GloboCare Corp. terminated Merger Agreement with YOOV Group Holding Limited (effective 2026-01-21).","evidence_excerpt":"The Termination Agreement terminates in its entirety, effective as of January 21, 2026, the Agreement and Plan of Merger dated March 7, 2025, by and among Avalon, Merger Sub and YOOV (the “Merger Agreement”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-006488","anchor_url":"https://secwatch.observer/filing/0001213900-26-006488#claim-ab499f6e0165ce61f6822a05d1b8d0be658805b8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390026006488/0001213900-26-006488-index.htm"},{"fact_type":"material_agreement","fact_key":"290f8081aa114908f119b80b5f5085d467a99a51","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-12-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"credit_facility","counterparty":"Allen O Cage Jr.","effective_date":"2025-12-11","item_codes_triggered":["1.01"],"value_text":"$375,000"},"claim":"Avalon GloboCare Corp. entered into Purchase Agreement with Allen O Cage Jr. valued at $375,000 (effective 2025-12-11).","evidence_excerpt":"On December 11, 2025, Avalon GloboCare Corp., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Allen O Cage Jr., an individual (the “Holder”), pursuant to which the Company issued an unsecured bridge note (the “Note”) with a maturity date of April 15, 2026 (the “Maturity Date”), in the principal sum of $375,000 (the “Principal Sum”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-121489","anchor_url":"https://secwatch.observer/filing/0001213900-25-121489#claim-290f8081aa114908f119b80b5f5085d467a99a51","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025121489/0001213900-25-121489-index.htm"},{"fact_type":"governance_change","fact_key":"813f7715816f11f0c8313e7b5d0d78d6dd762b81","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-12-15T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-12-12","item_codes_triggered":["5.03"],"summary_text":"Amended articles of incorporation to designate Series E Non-Voting Convertible Preferred Stock"},"claim":"Avalon GloboCare Corp.: Amended articles of incorporation to designate Series E Non-Voting Convertible Preferred Stock (effective 2025-12-12).","evidence_excerpt":"On December 12, 2025, the Company filed a certificate of designations of preferences, rights, and limitations of Series E Non-Voting Convertible Preferred Stock (the “Series E Certificate of Designations”) with the Department of State, Division of Corporations, of the State of Delaware, which provides for the designation of 19,500 shares of Series E Preferred Stock of the Company, par value $0.0001 per share, upon the terms and conditions as set forth in the Series E Certificate of Designations.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-121489","anchor_url":"https://secwatch.observer/filing/0001213900-25-121489#claim-813f7715816f11f0c8313e7b5d0d78d6dd762b81","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025121489/0001213900-25-121489-index.htm"},{"fact_type":"debt_financing","fact_key":"591b82ed80caa6d5630aaf032e38a06e6199a992","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-12-15T23:59:59+00:00","payload":{"counterparty":"Allen O Cage Jr.","effective_date":"2025-12-11","event":"incurrence","instrument_type":"loan","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"April 15, 2026","principal_text":"$375,000"},"claim":"Avalon GloboCare Corp. incurred loan of $375,000 with Allen O Cage Jr. maturing April 15, 2026.","evidence_excerpt":"On December 11, 2025, Avalon GloboCare Corp., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Allen O Cage Jr., an individual (the “Holder”), pursuant to which the Company issued an unsecured bridge note (the “Note”) with a maturity date of April 15, 2026 (the “Maturity Date”), in the principal sum of $375,000 (the “Principal Sum”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-121489","anchor_url":"https://secwatch.observer/filing/0001213900-25-121489#claim-591b82ed80caa6d5630aaf032e38a06e6199a992","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025121489/0001213900-25-121489-index.htm"},{"fact_type":"ma_transaction","fact_key":"a105e8a2c933c69f1014f4327383400903485e01","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-12-15T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2025-12-12","consideration_text":"$19,500,000","counterparty":"RPM INTERACTIVE, INC.","effective_date":"2025-12-12","item_codes_triggered":["2.01"]},"claim":"Avalon GloboCare Corp. completed an acquisition involving RPM INTERACTIVE, INC. for $19,500,000 (closed 2025-12-12).","evidence_excerpt":"Delaware corporation (the “Company” or “Avalon”), acquired RPM INTERACTIVE, INC., a Nevada corporation (“RPM”),\nin accordance with the terms of the Agreement and Plan of Merger, dated December 12, 2025, as amended by Amendment No.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-121489","anchor_url":"https://secwatch.observer/filing/0001213900-25-121489#claim-a105e8a2c933c69f1014f4327383400903485e01","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025121489/0001213900-25-121489-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"bc2eb6e200eb61f05e5a74551655dd1b23c88807","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-11-21T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-11-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 19, 2025, the\nCompany received a letter (the “November Nasdaq Letter”) from Nasdaq indicating that the Company was not in compliance with\nListing Rule 5550(b). Unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), trading\nof the Company’s common stock would be subject to suspension/delisting. Accordingly, the Company plans to timely request a hearing\nbefore the Panel, which request will automatically stay any suspension or delisting action by Nasdaq pending the hearing and the expiration\nof any additional extension period granted by the Panel fol","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-25-113638","anchor_url":"https://secwatch.observer/filing/0001213900-25-113638#claim-bc2eb6e200eb61f05e5a74551655dd1b23c88807","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025113638/0001213900-25-113638-index.htm"},{"fact_type":"governance_change","fact_key":"f35692127ed96ea64519fd836b7867031e8147c9","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-08-29T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-05-29","item_codes_triggered":["5.03"],"summary_text":"Amended beneficial ownership limitation in Series C Preferred Stock certificate of designations from 19.99% to 4.99%"},"claim":"Avalon GloboCare Corp.: Amended beneficial ownership limitation in Series C Preferred Stock certificate of designations from 19.99% to 4.99% (effective 2025-05-29).","evidence_excerpt":"On May 29, 2025, the Company filed a certificate of amendment to the Series C Certificate of Designations (the \"Certificate of Amendment\"), pursuant to which the beneficial ownership limitation of 19.99% was amended to 4.99%.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-082662","anchor_url":"https://secwatch.observer/filing/0001213900-25-082662#claim-f35692127ed96ea64519fd836b7867031e8147c9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025082662/0001213900-25-082662-index.htm"},{"fact_type":"debt_financing","fact_key":"180b9c61c8b2dba2a00e08f9182745cbb087315b","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-07-09T23:59:59+00:00","payload":{"counterparty":"two accredited investors","effective_date":"2025-07-03","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"one-time interest charge of $30,000","item_codes_triggered":["2.03"],"maturity_text":"nine months from the date of issuance","principal_text":"$100,000"},"claim":"Avalon GloboCare Corp. incurred convertible notes of $100,000 with two accredited investors at one-time interest charge of $30,000 maturing nine months from the date of issuance.","evidence_excerpt":"On July 3, 2025, Avalon GloboCare Corp., a Delaware corporation (the “Company”) issued two Convertible Promissory Notes (each, a “Note” and collectively, the “Notes”) to two accredited investors (each, an “Investor” and together, the “Investors”), on identical terms. Each Note had a principal amount of $100,000, bears a one-time interest charge of $30,000, and matures nine months from the date of issuance.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-062406","anchor_url":"https://secwatch.observer/filing/0001213900-25-062406#claim-180b9c61c8b2dba2a00e08f9182745cbb087315b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025062406/0001213900-25-062406-index.htm"},{"fact_type":"governance_change","fact_key":"9db2d26c1306326d16dee40b0e6daab4bde72199","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-06-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-05-29","item_codes_triggered":["5.03"],"summary_text":"Amended beneficial ownership limitation in Series C Certificate of Designations from 19.99% to 4.99%"},"claim":"Avalon GloboCare Corp.: Amended beneficial ownership limitation in Series C Certificate of Designations from 19.99% to 4.99% (effective 2025-05-29).","evidence_excerpt":"On May 29, 2025, the Company filed a certificate of amendment to the Series C Certificate of Designations (the “Certificate of Amendment”), pursuant to which the beneficial ownership limitation of 19.99% was amended to 4.99%.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-051193","anchor_url":"https://secwatch.observer/filing/0001213900-25-051193#claim-9db2d26c1306326d16dee40b0e6daab4bde72199","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025051193/0001213900-25-051193-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"64b4190f12f4623de28ae7e7189c1ec343cf328e","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-05-23T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2025-07-07","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"2500000","notice_date":"2025-05-22","notice_type":"deficiency_notice","plan_due_date":"2025-07-07","raw_rule_text":null,"reported_value":"-3891270","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 22, 2025, Avalon GloboCare Corp. (the “Company”)\nreceived a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nindicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The\nNasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of ($3,891,270), as reported\nin the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, was below the required minimum of $2.5 million,\nand because, as of May 22, 2025, the Compa","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001213900-25-047391","anchor_url":"https://secwatch.observer/filing/0001213900-25-047391#claim-64b4190f12f4623de28ae7e7189c1ec343cf328e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025047391/0001213900-25-047391-index.htm"},{"fact_type":"governance_change","fact_key":"33910eb3e3e9443efd54472c490e31d76e399b7f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-03-10T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2025-03-07","item_codes_triggered":["5.03"],"summary_text":"Reduced stockholder meeting quorum requirement to one-third of voting power"},"claim":"Avalon GloboCare Corp.: Reduced stockholder meeting quorum requirement to one-third of voting power (effective 2025-03-07).","evidence_excerpt":"The Amendment reduces the quorum at any meeting of stockholders, except as otherwise required by law or by the Avalon Charter or the Avalon Bylaws, to one-third of the voting power of the shares of capital stock outstanding and entitled to vote at the meeting, present in person, present by remote communication, if applicable, or represented by proxy.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-021943","anchor_url":"https://secwatch.observer/filing/0001213900-25-021943#claim-33910eb3e3e9443efd54472c490e31d76e399b7f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025021943/0001213900-25-021943-index.htm"},{"fact_type":"governance_change","fact_key":"16d6742073725c6e2ce28bc21145dc733ac6c126","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2025-03-10T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-03-07","item_codes_triggered":["5.03"],"summary_text":"Filed Certificates of Elimination to remove designations for Series A and Series B Preferred Stock from the certificate of incorporation"},"claim":"Avalon GloboCare Corp.: Filed Certificates of Elimination to remove designations for Series A and Series B Preferred Stock from the certificate of incorporation (effective 2025-03-07).","evidence_excerpt":"On March 7, 2025, Avalon filed a Certificate of Elimination relating to each of the Series A Preferred Stock and the Series B Preferred Stock (the “Eliminations of Designation”) with the Secretary of State of the State of Delaware, thereby terminating the designations of the Series A Preferred Stock and the Series B Preferred Stock.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-25-021943","anchor_url":"https://secwatch.observer/filing/0001213900-25-021943#claim-16d6742073725c6e2ce28bc21145dc733ac6c126","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025021943/0001213900-25-021943-index.htm"},{"fact_type":"governance_change","fact_key":"ed60d5cdc191414652e8de6700137f44940d36ac","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2024-12-19T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-12-13","item_codes_triggered":["5.03"],"summary_text":"Filed Series C Certificate of Designations to designate 10,000 shares of Series C Convertible Preferred Stock with stated value, dividend, liquidation preference, and conversion terms"},"claim":"Avalon GloboCare Corp.: Filed Series C Certificate of Designations to designate 10,000 shares of Series C Convertible Preferred Stock with stated value, dividend, liquidation preference, and conversion terms (effective 2024-12-13).","evidence_excerpt":"On December 13, 2024, the Company filed a certificate of designations of preferences, rights, and limitations of Series C Convertible Preferred Stock (the \"Series C Certificate of Designations\") with the Department of State, Division of Corporations, of the State of Delaware, which provides for the designation of 10,000 shares of Series C Preferred Stock of the Company, par value $0.0001 per share, upon the terms and conditions as set forth in the Series C Certificate of Designations.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-24-110582","anchor_url":"https://secwatch.observer/filing/0001213900-24-110582#claim-ed60d5cdc191414652e8de6700137f44940d36ac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390024110582/0001213900-24-110582-index.htm"},{"fact_type":"governance_change","fact_key":"d412ff28026f48311de916ff6d55ecdf008e3723","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2024-10-29T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-10-25","item_codes_triggered":["5.03"],"summary_text":"Reverse stock split at a ratio of 1-for-15 and decrease in authorized shares from 490,000,000 to 100,000,000"},"claim":"Avalon GloboCare Corp.: Reverse stock split at a ratio of 1-for-15 and decrease in authorized shares from 490,000,000 to 100,000,000 (effective 2024-10-25).","evidence_excerpt":"On October 23, 2024, the Company filed a certificate of amendment (the “Amendment”) to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effectuate the Reverse Stock Split at a ratio of 1-for-15 as well as the Decreased in Authorized Shares. The Amendment became effective at 5:00 PM ET on October 25, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-24-091819","anchor_url":"https://secwatch.observer/filing/0001213900-24-091819#claim-d412ff28026f48311de916ff6d55ecdf008e3723","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390024091819/0001213900-24-091819-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"34392c22046c7b6a481b57657b21f32475682bbf","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"extension_granted","cure_deadline":"2024-10-28","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-05-02","notice_type":"extension_granted","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"May 2, 2024, the Company\nreceived a letter from Nasdaq advising that the Company had been granted a 180-day extension to October 28, 2024, to regain compliance\nwith the Minimum Bid Price Requirement. The Company will continue\nto monitor the closing bid price of its Common Stock and may, if appropriate, consider implementing available options, including but not\nlimited to, implementing a reverse stock split of its Common Stock, to regain compliance with the Minimum Bid Price Requirement. If the\nCompany does not regain compliance within the allotted compliance period, Nasdaq will provide notice","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-24-040489","anchor_url":"https://secwatch.observer/filing/0001213900-24-040489#claim-34392c22046c7b6a481b57657b21f32475682bbf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390024040489/0001213900-24-040489-index.htm"},{"fact_type":"debt_financing","fact_key":"815b0d63fa96c2ca0b6b9dd08d91213e9e2e955a","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2024-03-27T23:59:59+00:00","payload":{"counterparty":"Mast Hill Fund L.P.","effective_date":"2024-03-27","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"13%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$700,000.00"},"claim":"Avalon GloboCare Corp. incurred convertible notes of $700,000.00 with Mast Hill Fund L.P. at 13%.","evidence_excerpt":"the issuance of 13% senior secured promissory notes totaling $700,000.00 convertible into common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-24-026600","anchor_url":"https://secwatch.observer/filing/0001213900-24-026600#claim-815b0d63fa96c2ca0b6b9dd08d91213e9e2e955a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390024026600/0001213900-24-026600-index.htm"},{"fact_type":"material_agreement","fact_key":"0822c935bbbde16181399bb9c76d982f491e3436","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2024-03-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Mortgage and Security Agreement dated March 27, 2024 (Mast Hill Mortgage)","agreement_type":"credit_facility","counterparty":"Mast Hill Fund L.P.","effective_date":"2024-03-27","item_codes_triggered":["1.01"],"value_text":"$2,200,000.00 combined principal sum"},"claim":"Avalon GloboCare Corp. entered into Mortgage and Security Agreement dated March 27, 2024 (Mast Hill Mortgage) with Mast Hill Fund L.P. valued at $2,200,000.00 combined principal sum (effective 2024-03-27).","evidence_excerpt":"On March 27, 2024, Avalon Globocare Corp. (the \"Company\") entered into a Mortgage and Security Agreement (the \"Mast Hill Mortgage\") with Mast Hill Fund L.P. (\"Mast Hill\") to secure the payment performance and obligation under certain follow-up financing agreements described below.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-24-026600","anchor_url":"https://secwatch.observer/filing/0001213900-24-026600#claim-0822c935bbbde16181399bb9c76d982f491e3436","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390024026600/0001213900-24-026600-index.htm"},{"fact_type":"material_agreement","fact_key":"192d0b48ca60409822c3f051acc7f08fc4cd2af0","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-11-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Membership Interest Purchase Agreement","agreement_type":"other","counterparty":"Wenzhao Lu","effective_date":"2023-11-17","item_codes_triggered":["1.01"],"value_text":"$3,000,000"},"claim":"Avalon GloboCare Corp. entered into Membership Interest Purchase Agreement with Wenzhao Lu valued at $3,000,000 (effective 2023-11-17).","evidence_excerpt":"On November 17, 2023, Avalon Globocare Corp., a Delaware corporation (the “Company”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Wenzhao Lu (the “Purchaser”), pursuant to which (i) the Purchaser acquired from the Company 30% of the total outstanding membership interests of Avalon RT 9 Properties, LLC, a wholly owned subsidiary of the Company (“Avalon RT9”) for a cash purchase price of $3,000,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-089631","anchor_url":"https://secwatch.observer/filing/0001213900-23-089631#claim-192d0b48ca60409822c3f051acc7f08fc4cd2af0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023089631/0001213900-23-089631-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d3f83b5f6dc7cf697792c5454f4ef1d28c864223","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-11-09T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-11-03","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"November 3, 2023, Avalon GloboCare Corp. (the\n“Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that\nthe closing bid price for the Company’s common stock had been below $1.00 per share for the previous 30 consecutive business days,\nand that the Company is therefore not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital\nMarket as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing\nor trading of the Company’s common stock on the Nasdaq Capital Market. In accordanc","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-085256","anchor_url":"https://secwatch.observer/filing/0001213900-23-085256#claim-d3f83b5f6dc7cf697792c5454f4ef1d28c864223","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023085256/0001213900-23-085256-index.htm"},{"fact_type":"debt_financing","fact_key":"27267dadc3193ac32ca13d66e8786495d98ad498","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"counterparty":"Firstfire Global Opportunities Fund, LLC","effective_date":"2023-10-11","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"13%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$350,000.00"},"claim":"Avalon GloboCare Corp. incurred senior notes of $350,000.00 with Firstfire Global Opportunities Fund, LLC at 13%.","evidence_excerpt":"Firstfire acquired the Notes with principal amount of $350,000.00 and paid the purchase price of $332,500.00 after an original issue discount of $17,500.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003840","anchor_url":"https://secwatch.observer/filing/0001013762-23-003840#claim-27267dadc3193ac32ca13d66e8786495d98ad498","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003840/0001013762-23-003840-index.htm"},{"fact_type":"debt_financing","fact_key":"e4aa98638f73275dc3d7d82ba4c9ed2f2e5941fe","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"counterparty":"Mast Hill Fund, L.P.","effective_date":"2023-10-11","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"13%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$350,000.00"},"claim":"Avalon GloboCare Corp. incurred senior notes of $350,000.00 with Mast Hill Fund, L.P. at 13%.","evidence_excerpt":"Mast Hill acquired the Notes with principal amount of $350,000.00 and paid the purchase price of $332,500.00 after an original issue discount of $17,500.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003840","anchor_url":"https://secwatch.observer/filing/0001013762-23-003840#claim-e4aa98638f73275dc3d7d82ba4c9ed2f2e5941fe","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003840/0001013762-23-003840-index.htm"},{"fact_type":"material_agreement","fact_key":"7f1d3224e926922644e8e253534d46b41c1d5f42","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Mortgage and Security Agreement","agreement_type":"credit_facility","counterparty":"Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC","effective_date":"2023-10-09","item_codes_triggered":["1.01"],"value_text":"Secures payment performance and obligation under the Notes in the combined principal sum of $700,000"},"claim":"Avalon GloboCare Corp. entered into Mortgage and Security Agreement with Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC valued at Secures payment performance and obligation under the Notes in the combined principal sum of $700,000 (effective 2023-10-09).","evidence_excerpt":"On October 9, 2023, the Company entered into mortgage and security agreement (the “Mortgage and Security Agreement”) with Mast Hill and Firstfire (the “Secured Parties”) to secure the payment performance and obligation under the Notes.","confidence":0.96,"filing_url":"https://secwatch.observer/filing/0001013762-23-003840","anchor_url":"https://secwatch.observer/filing/0001013762-23-003840#claim-7f1d3224e926922644e8e253534d46b41c1d5f42","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003840/0001013762-23-003840-index.htm"},{"fact_type":"material_agreement","fact_key":"9caa046d1524636c5369a0a7db6d6e9bd8728b1a","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Security Agreements","agreement_type":"credit_facility","counterparty":"Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC","effective_date":"2023-10-09","item_codes_triggered":["1.01"],"value_text":"Security interest in certain property of the Company and its subsidiaries to secure obligations unde"},"claim":"Avalon GloboCare Corp. entered into Security Agreements with Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC valued at Security interest in certain property of the Company and its subsidiaries to secure obligations unde (effective 2023-10-09).","evidence_excerpt":"The Company and its subsidiaries have entered into that certain security agreements (the “ Security Agreements ”), creating a security interest in certain property of the Company and its subsidiaries to secure the prompt payment, performance and discharge in full of all of the Company’s obligations under the Notes.","confidence":0.97,"filing_url":"https://secwatch.observer/filing/0001013762-23-003840","anchor_url":"https://secwatch.observer/filing/0001013762-23-003840#claim-9caa046d1524636c5369a0a7db6d6e9bd8728b1a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003840/0001013762-23-003840-index.htm"},{"fact_type":"material_agreement","fact_key":"69d966499c84bda12fb2209ced643edc50f6f094","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreements","agreement_type":"notes_offering","counterparty":"Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC","effective_date":"2023-10-09","item_codes_triggered":["1.01"],"value_text":"13% senior secured promissory notes in the aggregate principal amount of $700,000.00, convertible in"},"claim":"Avalon GloboCare Corp. entered into Securities Purchase Agreements with Mast Hill Fund, L.P. and Firstfire Global Opportunities Fund, LLC valued at 13% senior secured promissory notes in the aggregate principal amount of $700,000.00, convertible in (effective 2023-10-09).","evidence_excerpt":"On October 9, 2023, AVALON GLOBOCARE CORP. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) with Mast Hill Fund, L.P. (“Mast Hill”) and Firstfire Global Opportunities Fund, LLC. (“Firstfire”) for the issuance of 13% senior secured promissory notes in the aggregate principal amount of $700,000.00 (collectively the “ Notes ”) convertible into shares of common stock, par value $0.0001 per share, of the Company, as well as the issuance of up to 70,000 shares of common stock as a commitment fee and warrants for the purchase of up to 105,000 shares of Common Stock at an initial price per share of $2.50 and common share purchase warrants for the purchase of up to 87,500 shares of Common Stock at an initial price per share of $1.80 (collectively, the “October 2023 Warrants”).","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001013762-23-003840","anchor_url":"https://secwatch.observer/filing/0001013762-23-003840#claim-69d966499c84bda12fb2209ced643edc50f6f094","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003840/0001013762-23-003840-index.htm"},{"fact_type":"shareholder_vote","fact_key":"89a408c4c7b29c5ef38f8823cb1e4f62d1dd7dfc","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Advisory vote on frequency of future advisory votes on executive compensation","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"1,707,228","subject":null,"votes_abstain":"2,631","votes_against":null,"votes_for":"5,529,740","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-10-12 meeting.","evidence_excerpt":"ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 5,529,740 21,533 3,545 2,631 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-89a408c4c7b29c5ef38f8823cb1e4f62d1dd7dfc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"013ea638a5cec1c13bfa523be80f4759ff2eaa68","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Advisory vote on compensation of named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,707,228","subject":null,"votes_abstain":"6,770","votes_against":"32,782","votes_for":"5,517,897","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Advisory vote on compensation of named executive officers at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,517,897 32,782 6,770 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-013ea638a5cec1c13bfa523be80f4759ff2eaa68","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a17dacdf72f037bac23b733612c91ea48037e5e3","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Approve the Amended and Restated 2020 Stock Incentive Plan (Plan Proposal)","proposal_type":"equity_plan","results":[{"broker_non_votes":"1,707,228","subject":null,"votes_abstain":"18,424","votes_against":"87,665","votes_for":"5,451,360","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approve the Amended and Restated 2020 Stock Incentive Plan (Plan Proposal) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,451,360 87,665 18,424 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-a17dacdf72f037bac23b733612c91ea48037e5e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"0702cd5205e40bb235f12e15a3909ec7f30ca2cf","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Approve the Note Share Issuance Proposal (potential issuance of shares pursuant to May and July securities purchase agreements, notes, and warrants)","proposal_type":"other","results":[{"broker_non_votes":"1,707,228","subject":null,"votes_abstain":"17,731","votes_against":"20,888","votes_for":"5,518,830","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approve the Note Share Issuance Proposal (potential issuance of shares pursuant to May and July securities purchase agreements, notes, and warrants) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,830 20,888 17,731 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-0702cd5205e40bb235f12e15a3909ec7f30ca2cf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e025c94ff2974390caed13109b6ec3acb03076d9","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Approve the Preferred Share Issuance Proposal (potential issuance of shares upon conversion of Series A and Series B Convertible Preferred Stock in connection with acquisition of Laboratory Services MSO, LLC)","proposal_type":"other","results":[{"broker_non_votes":"1,707,228","subject":null,"votes_abstain":"17,138","votes_against":"21,487","votes_for":"5,518,824","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Approve the Preferred Share Issuance Proposal (potential issuance of shares upon conversion of Series A and Series B Convertible Preferred Stock in connection with acquisition of Laboratory Services MSO, LLC) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,824 21,487 17,138 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-e025c94ff2974390caed13109b6ec3acb03076d9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"c14976c2e44c4516f5ee2eda95797dbbdcf57c57","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"32,630","votes_against":"13,827","votes_for":"7,218,220","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 7,218,220 13,827 32,630 N/A","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-c14976c2e44c4516f5ee2eda95797dbbdcf57c57","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"shareholder_vote","fact_key":"76b20986578bf99484dcb549c441c820dcaa09e4","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-10-12","outcome":"passed","proposal_text":"Election of seven directors","proposal_type":"director_election","results":[{"broker_non_votes":"1,707,228","subject":"Wenzhao Lu","votes_abstain":null,"votes_against":null,"votes_for":"5,528,621","votes_withheld":"28,828"},{"broker_non_votes":"1,707,228","subject":"David Jin, MD, PhD","votes_abstain":null,"votes_against":null,"votes_for":"5,550,026","votes_withheld":"7,423"},{"broker_non_votes":"1,707,228","subject":"Steven A. Sanders","votes_abstain":null,"votes_against":null,"votes_for":"5,503,532","votes_withheld":"53,917"},{"broker_non_votes":"1,707,228","subject":"Lourdes Felix","votes_abstain":null,"votes_against":null,"votes_for":"5,525,718","votes_withheld":"31,731"},{"broker_non_votes":"1,707,228","subject":"Wilbert J. Tauzin II","votes_abstain":null,"votes_against":null,"votes_for":"5,530,783","votes_withheld":"26,666"},{"broker_non_votes":"1,707,228","subject":"William B. Stilley, III","votes_abstain":null,"votes_against":null,"votes_for":"5,502,958","votes_withheld":"54,491"},{"broker_non_votes":"1,707,228","subject":"Tevi Troy","votes_abstain":null,"votes_against":null,"votes_for":"5,503,496","votes_withheld":"53,953"}]},"claim":"Avalon GloboCare Corp. shareholders approved Election of seven directors at the 2023-10-12 meeting.","evidence_excerpt":"FOR WITHHELD BROKER NON-VOTES Wenzhao Lu 5,528,621 28,828 1,707,228 David Jin, MD, PhD 5,550,026 7,423 1,707,228 Steven A. Sanders 5,503,532 53,917 1,707,228 Lourdes Felix 5,525,718 31,731 1,707,228 Wilbert J. Tauzin II 5,530,783 26,666 1,707,228 William B. Stilley, III 5,502,958 54,491 1,707,228 Tevi Troy 5,503,496 53,953 1,707,228","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001013762-23-003650","anchor_url":"https://secwatch.observer/filing/0001013762-23-003650#claim-76b20986578bf99484dcb549c441c820dcaa09e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm"},{"fact_type":"debt_financing","fact_key":"38dec6b502eb485625cba1fb64467ec260c13e36","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-07-10T23:59:59+00:00","payload":{"counterparty":"Firstfire Global Opportunities Fund, LLC","effective_date":"2023-07-07","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"13%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$500,000.00"},"claim":"Avalon GloboCare Corp. incurred convertible notes of $500,000.00 with Firstfire Global Opportunities Fund, LLC at 13%.","evidence_excerpt":"On July 6, 2023, AVALON GLOBOCARE CORP. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) with Firstfire Global Opportunities Fund, LLC (“ Firstfire ”) for the issuance of 13% senior secured promissory notes in the aggregate principal amount of $500,000.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-055582","anchor_url":"https://secwatch.observer/filing/0001213900-23-055582#claim-38dec6b502eb485625cba1fb64467ec260c13e36","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023055582/0001213900-23-055582-index.htm"},{"fact_type":"material_agreement","fact_key":"d5effa2c0315332dce6c5e42b81b3e719a924208","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-07-10T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreements","agreement_type":"notes_offering","counterparty":"Firstfire Global Opportunities Fund, LLC","effective_date":"2023-07-06","item_codes_triggered":["1.01"],"value_text":"$500,000.00"},"claim":"Avalon GloboCare Corp. entered into Securities Purchase Agreements with Firstfire Global Opportunities Fund, LLC valued at $500,000.00 (effective 2023-07-06).","evidence_excerpt":"On July 6, 2023, AVALON GLOBOCARE CORP. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) with Firstfire Global Opportunities Fund, LLC (“ Firstfire ”) for the issuance of 13% senior secured promissory notes in the aggregate principal amount of $500,000.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-055582","anchor_url":"https://secwatch.observer/filing/0001213900-23-055582#claim-d5effa2c0315332dce6c5e42b81b3e719a924208","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023055582/0001213900-23-055582-index.htm"},{"fact_type":"material_agreement","fact_key":"6f0ea3ca39804e5eac85b1f4f9b25f4798b5ba3f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-06-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Sales Agreement","agreement_type":"atm_program","counterparty":"Roth Capital Partners, LLC","effective_date":"2023-06-16","item_codes_triggered":["1.01"],"value_text":"up to $3,500,000"},"claim":"Avalon GloboCare Corp. entered into Sales Agreement with Roth Capital Partners, LLC valued at up to $3,500,000 (effective 2023-06-16).","evidence_excerpt":"On June 16, 2023, Avalon GloboCare Corp. (the “Company”) entered into that certain sales agreement (the “Sales Agreement”) with Roth Capital Partners, LLC (“Roth”), as sales agent, pursuant to which the Company may issue and sell, from time to time, through Roth, shares of its common stock, par value $0.0001 per share (the “Common Stock”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-049645","anchor_url":"https://secwatch.observer/filing/0001213900-23-049645#claim-6f0ea3ca39804e5eac85b1f4f9b25f4798b5ba3f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023049645/0001213900-23-049645-index.htm"},{"fact_type":"debt_financing","fact_key":"defd6b13cf363575d9375cdc8b898199f75ea510","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-05-26T23:59:59+00:00","payload":{"counterparty":"Mast Hill Fund, L.P.","effective_date":"2023-05-23","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"13%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$1,500,000.00"},"claim":"Avalon GloboCare Corp. incurred convertible notes of $1,500,000.00 with Mast Hill Fund, L.P. at 13%.","evidence_excerpt":"On May 23, 2023, AVALON GLOBOCARE CORP. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) with Mast Hill Fund, L.P. (“ Mast Hill ”) for the issuance of 13% senior secured promissory notes in the aggregate principal amount of $1,500,000.00 (collectively the “ Notes ”) convertible into shares of common stock, par value $0.0001 per share, of the Company, as well as the issuance of up to 75,000 shares of common stock as a commitment fee and warrants for the purchase of up to 230,000 shares of common stock of the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-043586","anchor_url":"https://secwatch.observer/filing/0001213900-23-043586#claim-defd6b13cf363575d9375cdc8b898199f75ea510","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023043586/0001213900-23-043586-index.htm"},{"fact_type":"debt_financing","fact_key":"1d901b45b6f31e7fff8c0b227377f4ba7414c9ed","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-05-26T23:59:59+00:00","payload":{"counterparty":"S&P Principal LLC","effective_date":"2023-05-24","event":"incurrence","instrument_type":"mortgage","interest_rate_text":"accrue interest at the annual rate of 13.0%","item_codes_triggered":["2.03"],"maturity_text":"October, 2025","principal_text":"$1,000,000.00"},"claim":"Avalon GloboCare Corp. incurred mortgage of $1,000,000.00 with S&P Principal LLC at accrue interest at the annual rate of 13.0% maturing October, 2025.","evidence_excerpt":"On May 18, 2023, the Company, as sole member of Avalon RT9 Properties, LLC, a New Jersey limited liability company (“ Avalon RT9 ”), authorized Avalon RT9 to execute and deliver, that certain balloon mortgage note, dated May 24, 2023 in favor of S&P Principal LLC (the “ Lender ”) in the original principal amount of $1,000,000.00 (the “ Balloon Mortgage Note ”), which Balloon Mortgage Note shall accrue interest at the annual rate of 13.0% and be paid in monthly installments of interest-only in the amount of $10,833.33 commencing in June, 2023 and continuing through October, 2025 (at which point any unpaid balance of principal, interest and other charges shall be due and payable), and be secured by a second-lien mortgage on certain real property and improvements located at 4400 Route 9, Freehold, Monmouth County, New Jersey, as evidenced by that Second Mortgage and Security Agreement dated May 24, 2023 (the “ Mortgage ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-043586","anchor_url":"https://secwatch.observer/filing/0001213900-23-043586#claim-1d901b45b6f31e7fff8c0b227377f4ba7414c9ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023043586/0001213900-23-043586-index.htm"},{"fact_type":"material_agreement","fact_key":"0c3bafd854bb69c0b5b2cd0efb35de76b21c96c7","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-05-26T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement (Convertible Note Financing)","agreement_type":"notes_offering","counterparty":"Mast Hill Fund, L.P.","effective_date":"2023-05-23","item_codes_triggered":["1.01"],"value_text":"aggregate principal amount of $1,500,000.00, convertible into common stock at $4.5 per share, with w"},"claim":"Avalon GloboCare Corp. entered into Securities Purchase Agreement (Convertible Note Financing) with Mast Hill Fund, L.P. valued at aggregate principal amount of $1,500,000.00, convertible into common stock at $4.5 per share, with w (effective 2023-05-23).","evidence_excerpt":"Convertible Note Financing On May 23, 2023, AVALON GLOBOCARE CORP. (the “ Company ”) entered into securities purchase agreements (the “ Securities Purchase Agreements ”) with Mast Hill Fund, L.P. (“ Mast Hill ”) for the issuance of 13% senior secured promissory notes in the aggregate principal amount of $1,500,000.00 (collectively the “ Notes ”) convertible into shares of common stock, par value $0.0001 per share, of the Company, as well as the issuance of up to 75,000 shares of common stock as a commitment fee and warrants for the purchase of up to 230,000 shares of common stock of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-043586","anchor_url":"https://secwatch.observer/filing/0001213900-23-043586#claim-0c3bafd854bb69c0b5b2cd0efb35de76b21c96c7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023043586/0001213900-23-043586-index.htm"},{"fact_type":"material_agreement","fact_key":"92af97afd19a34d0290bba3536fea587da7c1479","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-05-26T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Balloon Mortgage Note","agreement_type":"credit_facility","counterparty":"S&P Principal LLC","effective_date":"2023-05-24","item_codes_triggered":["1.01"],"value_text":"$1,000,000.00 principal amount, 13% annual interest"},"claim":"Avalon GloboCare Corp. entered into Balloon Mortgage Note with S&P Principal LLC valued at $1,000,000.00 principal amount, 13% annual interest (effective 2023-05-24).","evidence_excerpt":"Balloon Mortgage Note On May 18, 2023, the Company, as sole member of Avalon RT9 Properties, LLC, a New Jersey limited liability company (“ Avalon RT9 ”), authorized Avalon RT9 to execute and deliver, that certain balloon mortgage note, dated May 24, 2023 in favor of S&P Principal LLC (the “ Lender ”) in the original principal amount of $1,000,000.00 (the “ Balloon Mortgage Note ”), which Balloon Mortgage Note shall accrue interest at the annual rate of 13.0% and be paid in monthly installments of interest-only in the amount of $10,833.33 commencing in June, 2023 and continuing through October, 2025 (at which point any unpaid balance of principal, interest and other charges shall be due and payable), and be secured by a second-lien mortgage on certain real property and improvements located at 4400 Route 9, Freehold, Monmouth County, New Jersey, as evidenced by that Second Mortgage and Security Agreement dated May 24, 2023 (the “ Mortgage ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-23-043586","anchor_url":"https://secwatch.observer/filing/0001213900-23-043586#claim-92af97afd19a34d0290bba3536fea587da7c1479","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023043586/0001213900-23-043586-index.htm"},{"fact_type":"earnings_release","fact_key":"dce577c24be89658d38b311d2b876b8c92899a8b","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-04-27T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$6.3 million","period_text":"the twelve months ended December 31, 2022","report_date":"2023-04-27","result_type":"reported_results","revenue_text":"$14.7 million"},"claim":"Avalon GloboCare Corp. reported the twelve months ended December 31, 2022 results: revenue $14.7 million, net income $6.3 million.","evidence_excerpt":"LSM 2022 Financial Highlights · Revenue was $14.7 million · Gross profit was $8.1 million · Total operating expense was $2.4 million · Net income was $6.3 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-033285","anchor_url":"https://secwatch.observer/filing/0001213900-23-033285#claim-dce577c24be89658d38b311d2b876b8c92899a8b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/0001213900-23-033285-index.htm"},{"fact_type":"ma_transaction","fact_key":"86850f5103daa78e0608f9e9e7b852b73b861e7c","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-02-13T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2023-02-09","consideration_text":"$21,000,000","counterparty":"SCBC Holdings LLC","effective_date":"2023-02-09","item_codes_triggered":["2.01"]},"claim":"Avalon GloboCare Corp. completed an acquisition involving SCBC Holdings LLC for $21,000,000 (closed 2023-02-09).","evidence_excerpt":"Services MSO (the “ Purchased Interests ”), free and clear of all liens (the\n“ Transaction ”). The consideration paid by Buyer to Seller for the Purchased Interests consisted of $21,000,000, which\ncomprised of (i) $9,000,000 in cash, (ii) $11,000,000 pursuant to the issuance of 11,000 shares of the Company’s newly designated\nSeries B Convertible Preferred Stock (the “","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-010503","anchor_url":"https://secwatch.observer/filing/0001213900-23-010503#claim-86850f5103daa78e0608f9e9e7b852b73b861e7c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/0001213900-23-010503-index.htm"},{"fact_type":"material_agreement","fact_key":"f405be70bf3ffbc164b4f9b77686ac61e63b4ce3","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-02-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Amended MIPA","agreement_type":"other","counterparty":"Seller","effective_date":null,"item_codes_triggered":["1.01"],"value_text":null},"claim":"Avalon GloboCare Corp. entered into Amended MIPA with Seller.","evidence_excerpt":"he Series B Preferred Stock to the Seller, the terms of which are set forth below. The Company designated up to 15,000 shares of the","confidence":0.4,"filing_url":"https://secwatch.observer/filing/0001213900-23-010503","anchor_url":"https://secwatch.observer/filing/0001213900-23-010503#claim-f405be70bf3ffbc164b4f9b77686ac61e63b4ce3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/0001213900-23-010503-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"91d5e074ea7d7803119db89cf5a6ae3a9363a408","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-01-23T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"regained_compliance","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-01-20","notice_type":"compliance_regained","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"Avalon GloboCare Corp. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"January 20, 2023, the Company received a letter from the Staff of Nasdaq indicating that it has regained compliance with the Minimum Bid\nRequirement and this matter is now closed. SIGNATURES Pursuant to the requirements of the Securities and\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: January 23, 2023 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-004290","anchor_url":"https://secwatch.observer/filing/0001213900-23-004290#claim-91d5e074ea7d7803119db89cf5a6ae3a9363a408","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023004290/0001213900-23-004290-index.htm"},{"fact_type":"governance_change","fact_key":"de6124bca2b200b86f8c16ee37f6ce5e93cf31df","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2023-01-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-01-05","item_codes_triggered":["5.03"],"summary_text":"Effected a 1-to-10 reverse stock split of common stock via a Certificate of Amendment to the Certificate of Incorporation"},"claim":"Avalon GloboCare Corp.: Effected a 1-to-10 reverse stock split of common stock via a Certificate of Amendment to the Certificate of Incorporation (effective 2023-01-05).","evidence_excerpt":"On December 22, 2022, the Company, filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware (the \"Certificate of Amendment\"), which effected a reverse stock split of its common stock at a ratio of 1-to-10 with an effective time of, 12:01 a.m. eastern time, January 5, 2023","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-000680","anchor_url":"https://secwatch.observer/filing/0001213900-23-000680#claim-de6124bca2b200b86f8c16ee37f6ce5e93cf31df","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023000680/0001213900-23-000680-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a98816ef72cd5624975ea05ccc6e592da175840e","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-12-30T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-29","outcome":"passed","proposal_text":"Ratify the appointment of MARCUM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022.","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"62,977","votes_against":"77,386","votes_for":"71,144,419","votes_withheld":null}]},"claim":"Avalon GloboCare Corp. shareholders approved Ratify the appointment of MARCUM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. at the 2022-12-29 meeting.","evidence_excerpt":"(2) Ratify the appointment of MARCUM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022. This matter was determined based on majority of the shares cast. For Against Abstain 71,144,419 77,386 62,977","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-083726","anchor_url":"https://secwatch.observer/filing/0001213900-22-083726#claim-a98816ef72cd5624975ea05ccc6e592da175840e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022083726/0001213900-22-083726-index.htm"},{"fact_type":"shareholder_vote","fact_key":"567bbc0154d6a157d48597c23f2292321c216792","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-12-30T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-29","outcome":"passed","proposal_text":"Elect six directors until his successor is duly elected and qualified, or until his earlier death, resignation or removal.","proposal_type":"director_election","results":[{"broker_non_votes":null,"subject":"Wenzhao “Daniel” Lu","votes_abstain":null,"votes_against":null,"votes_for":"53,982,841","votes_withheld":"590,963"},{"broker_non_votes":null,"subject":"David Jin, MD, PhD","votes_abstain":null,"votes_against":null,"votes_for":"54,000,145","votes_withheld":"573,659"},{"broker_non_votes":null,"subject":"Steven A. Sanders","votes_abstain":null,"votes_against":null,"votes_for":"53,931,438","votes_withheld":"642,366"},{"broker_non_votes":null,"subject":"Wilbert J. Tauzin, II","votes_abstain":null,"votes_against":null,"votes_for":"53,984,652","votes_withheld":"589,152"},{"broker_non_votes":null,"subject":"William B. Stilley, III","votes_abstain":null,"votes_against":null,"votes_for":"53,939,369","votes_withheld":"634,435"},{"broker_non_votes":null,"subject":"Tevi Troy","votes_abstain":null,"votes_against":null,"votes_for":"53,939,946","votes_withheld":"633,858"}]},"claim":"Avalon GloboCare Corp. shareholders approved Elect six directors until his successor is duly elected and qualified, or until his earlier death, resignation or removal. at the 2022-12-29 meeting.","evidence_excerpt":"(1) Elect six directors until his successor is duly elected and qualified, or until his earlier death, resignation or removal. The six directors receiving the highest vote were appointed to the board. The following Directors were elected to the board. For Withheld Wenzhao “Daniel” Lu 53,982,841 590,963 David Jin, MD, PhD 54,000,145 573,659 Steven A. Sanders 53,931,438 642,366 Wilbert J. Tauzin, II 53,984,652 589,152 William B. Stilley, III 53,939,369 634,435 Tevi Troy 53,939,946 633,858","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-083726","anchor_url":"https://secwatch.observer/filing/0001213900-22-083726#claim-567bbc0154d6a157d48597c23f2292321c216792","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022083726/0001213900-22-083726-index.htm"},{"fact_type":"governance_change","fact_key":"ac7e0a44b5e880c38303d896c828d20120dd214f","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-12-14T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2022-11-03","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Designation for Series A Preferred Stock, designating up to 15,000 shares and setting preferences, rights, and limitations."},"claim":"Avalon GloboCare Corp.: Filed Certificate of Designation for Series A Preferred Stock, designating up to 15,000 shares and setting preferences, rights, and limitations (effective 2022-11-03).","evidence_excerpt":"On November 3, 2022 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock (the “ Series A Certificate of Designation ”), which became effective immediately with the Secretary of State of the State of Delaware, attached hereto as Exhibit 3.1.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-079631","anchor_url":"https://secwatch.observer/filing/0001213900-22-079631#claim-ac7e0a44b5e880c38303d896c828d20120dd214f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/0001213900-22-079631-index.htm"},{"fact_type":"material_agreement","fact_key":"3a44855fea490c739aa47da11a5a4fac9d289afc","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-12-14T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Wenzhao Lu","effective_date":"2022-12-14","item_codes_triggered":["1.01"],"value_text":"$4,000,000"},"claim":"Avalon GloboCare Corp. entered into Securities Purchase Agreement with Wenzhao Lu valued at $4,000,000 (effective 2022-12-14).","evidence_excerpt":"On December 14, 2022, the Company entered into a Securities Purchase Agreement with Wenzhao Lu, the Company’s Chairman of the Board, pursuant to which the Company sold to Mr. Lu 4,000 shares of its Series A Preferred Stock, stated value $1,000, for the gross proceeds of $4,000,000 (the “ Private Placement ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-079631","anchor_url":"https://secwatch.observer/filing/0001213900-22-079631#claim-3a44855fea490c739aa47da11a5a4fac9d289afc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022079631/0001213900-22-079631-index.htm"},{"fact_type":"governance_change","fact_key":"4516769d883f441c0e3033bee8b7a8987645dfa5","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-11-08T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2022-11-03","item_codes_triggered":["5.03"],"summary_text":"Filed a Certificate of Designation for Series A Preferred Stock with the Delaware Secretary of State, effective immediately on November 3, 2022."},"claim":"Avalon GloboCare Corp.: Filed a Certificate of Designation for Series A Preferred Stock with the Delaware Secretary of State, effective immediately on November 3, 2022 (effective 2022-11-03).","evidence_excerpt":"on November 3, 2022 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock (the “ Series A Certificate of Designation ”), which became effective immediately with the Secretary of State of the State of Delaware","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-069925","anchor_url":"https://secwatch.observer/filing/0001213900-22-069925#claim-4516769d883f441c0e3033bee8b7a8987645dfa5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm"},{"fact_type":"material_agreement","fact_key":"299915126cbe4cb9a06a525d0297d0c8e0597ab5","cik":1630212,"ticker":"ALBT","company_name":"Avalon GloboCare Corp.","filed_at":"2022-11-08T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Membership Interest Purchase Agreement","agreement_type":"asset_purchase","counterparty":"SCBC Holdings LLC","effective_date":"2022-11-07","item_codes_triggered":["1.01"],"value_text":"up to thirty-one million dollars ($31,000,000)"},"claim":"Avalon GloboCare Corp. entered into Membership Interest Purchase Agreement with SCBC Holdings LLC valued at up to thirty-one million dollars ($31,000,000) (effective 2022-11-07).","evidence_excerpt":"On November 7, 2022, Avalon Laboratory Services, Inc. (the “ Buyer ”), a wholly-owned subsidiary of Avalon GloboCare Corp. (the “ Company ”), entered into a Membership Interest Purchase Agreement (the “ MIPA ”), by and among SCBC Holdings LLC (the “ Seller ”), the Zoe Family Trust, and Bryan Cox and Sarah Cox as individuals (each an “ Owner ” and collectively, the “ Owners ”), and Laboratory Services MSO, LLC (“ Laboratory Services MSO ”), pursuant to which, subject to the terms and conditions set forth in the MIPA, the Buyer will acquire from the Seller, sixty percent (60%) of all the issued and outstanding equity interests of the Laboratory Services MSO (the “ Purchased Interests ”), free and clear of all liens (the “ Transaction ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-22-069925","anchor_url":"https://secwatch.observer/filing/0001213900-22-069925#claim-299915126cbe4cb9a06a525d0297d0c8e0597ab5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm"}]}